Paris, France

Nicolas Danchin

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 4.8

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2017-2021

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: **Nicolas Danchin: Innovator in Cardiovascular Health**

Introduction

Nicolas Danchin, based in Paris, France, is a notable inventor in the field of cardiovascular health. With two patents to his name, he has made significant contributions to predicting and improving patient outcomes related to cardiovascular diseases. His innovative methods reflect a dedication to advancing medical science and enhancing patient care.

Latest Patents

Danchin's latest patents focus on methods for assessing cardiovascular risk and survival in patients. The first patent presents a groundbreaking method for predicting the risk of a cardiovascular event or disease by measuring the expression level of soluble Triggering Receptors Expressed on Myeloid cells-1 (sTREM-1) in patient samples. By comparing these levels to a reference, healthcare providers can identify at-risk individuals and administer appropriate therapies, potentially preventing serious cardiovascular issues.

The second patent details a method for predicting survival time in patients experiencing myocardial infarction. This method involves determining the expression level of B-cell activation factor (BAFF) in patient samples, comparing it to a predetermined reference value. Depending on this comparison, clinicians can provide prognostic information regarding the patient's survival time and the risk of myocardial recurrence.

Career Highlights

Nicolas Danchin has worked with esteemed organizations, including the Institut National de la Santé et de la Recherche Médicale (INSERM) and Inotrem. His career reflects a commitment to research and innovation, directly impacting patient care in the realm of cardiology.

Collaborations

Throughout his career, Danchin has collaborated with notable professionals, including Marc Derive and Sebastien Gibot. These partnerships have fostered a rich environment for innovation and progress in cardiovascular research.

Conclusion

Nicolas Danchin's contributions as an inventor are pivotal in the ongoing fight against cardiovascular diseases. His innovative patents not only highlight his expertise but also carry the potential to significantly improve patient outcomes. With a focus on research and collaboration, Danchin continues to be a prominent figure in the advancement of medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…